Prestige Consumer Healthcare reports mixed fiscal 2026 results, announces LaCorium deal
Prestige Consumer Healthcare Inc. (NYSE: PBH) reported fiscal 2026 revenues of $1,088.7 million, down 4.3% from the prior year's $1,137.8 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
